BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10463479)

  • 1. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.
    Yoo J; Robinson RA; Lee JY
    Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
    Yoo J; Robinson RA
    Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-ras-1 point mutations in soft tissue sarcomas.
    Wilke W; Maillet M; Robinson R
    Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
    Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
    Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
    Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
    Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of K-ras mutations in resected primary leiomyosarcoma.
    Hill MA; Gong C; Casey TJ; Menon AG; Mera R; Gillespie AT; Giardina JF; Levine EA; Hunt JD
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1095-100. PubMed ID: 9419409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.
    Tada M; Omata M; Ohto M
    Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients.
    Jin Y; Shima Y; Furu M; Aoyama T; Nakamata T; Nakayama T; Nakamura T; Toguchida J
    Anticancer Res; 2010 Jan; 30(1):245-51. PubMed ID: 20150643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ras gene mutations in human prostate cancer.
    Carter BS; Epstein JI; Isaacs WB
    Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
    Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
    Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-ras-1 gene mutations in basal cell carcinoma: automated direct sequencing of clinical specimens.
    Wilke WW; Robinson RA; Kennard CD
    Mod Pathol; 1993 Jan; 6(1):15-9. PubMed ID: 8426854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of ras gene family in lung cancer in Thai.
    Petmitr S; Wongsommart D; Chaksangchaichot P; Pakeetoot T; Sutinont P; Sirivaidyapong P; Karalak A
    Oncol Rep; 2003; 10(5):1497-501. PubMed ID: 12883730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the p53 gene in postradiation sarcoma.
    Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
    Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma.
    Nicolaides A; Huang YQ; Li JJ; Zhang WG; Friedman-Kien AE
    Anticancer Res; 1994; 14(3A):921-6. PubMed ID: 8074494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.